Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of CGRP antagonists and CGRP release inhibitors for combating menopausal hot flushes

Use of CGRP antagonists and CGRP release inhibitors for combating menopausal hot flushes

US Patent 6521609 · Granted Feb 18, 2003

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

(cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles2025
Modulators of complex I2024
Modulators of complex I2023
(Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles2023
(Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles2021
Somatostatin receptor subtype 4 (SSTR4) agonists2020
Somatostatin receptor subtype 4 (SSTR4) agonists2020
Morpholine and 1,4-oxazepane amides as somatostatin receptor subtype 4 (SSTR4) a2020
(Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles2020
Method for producing a coated body hardened by hot forming as well as a body pro2019
Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrop2019
Somatostatin receptor subtype 4 (SSTR4) agonists2019